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ABSTRACT 
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Diffusion-weighted imaging (DWI) is a novel magnetic resonance imaging (MRI) tech-
nique sensitive to Brownian motion. With the use of diffusion-sensitizing gradient puls-
es DWI enables the detection of microscopic diffusion of water molecules in biological 
tissues. Diffusion state for different voxels can be calculated from DW images with dif-
ferent diffusion weightings, resulting a quantitative apparent diffusion coefficient 
(ADC) map. Different tissues restrict diffusion in different ways, which makes DWI 
sensitive for alterations in movement of water molecules in normal versus abnormal 
tissue. So far DWI has been used clinically mainly for imaging brain disorders but ap-
plications on oncology are also promising. Breast cancer imaging is one potential appli-
cation for DW imaging. The ADC values of malign breast lesions are usually lower than 
those of benign lesions, which makes DWI a potential tool for differentiating lesion 
types. DWI has multiple advantages over conventional contrast-enhanced MRI, for ex-
ample it is cheaper and faster than DCE-MRI and to top it all it increases the sensitivity 
of breast lesion characterization. 
 In this Master of Science thesis 45 patients with 48 ductal carcinoma and 8 be-
nign lesions were examined through four different studies: comparison of mean ADC 
values of benign and malign breast lesions, repeatability of ADC measurements, corre-
lation between ADC values and Signal-to-Noise ratio and effect of lesions size to the 
ADC values. The statistical significance of the results was analyzed with statistical tests 
with SPSS software. 
 The normalized mean ADC values for benign lesions was found  
0.80 ± 0.23 x10-3 mm2/s and for malign lesions 0.63 ± 0.20 x10-3 mm2/s and they were 
found significantly different. The cutoff value for malign lesions was determined  
0.83 x10-3 mm2/s with sensitivity of 83.3% and specificity of 37.3%. The measurement 
method showed excellent repeatability (ICC 0.94), especially with big lesions. ADC and 
SNR values did not have significant correlation. These results were promising and they 
give a basis for further studies, like for studies with larger sample size and with several 
different malign lesion types. In the future the cutoff value of malign and benign lesions 
could be used as guidance tool for doctors in breast lesion characterization. 
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Diffuusio-painotettu magneettikuvantaminen (Diffusion-Weighted Imaging, DWI) on 
uudenlainen lääketieteellinen kuvantamismenetelmä, joka perustuu vesimolekyylien 
Brownian liikkeeseen. DWI-tekniikka käyttää erityisiä herkistyspulsseja mitatessaan 
vesimolekyylien diffuusiota biologisissa kudoksissa. Diffuusion voimakkuutta eri kuva-
alkioissa voidaan kuvata näennäisdiffuusiovakioilla (Apparent Diffusion Coefficient, 
ADC), joista voidaan muodostaa ADC-karttoja. ADC-kartat ovat lääketieteellisiä kuvia, 
joiden muodostamiseen käytetään kahta tai useampaa eri herkistyspulsseilla saatua dif-
fuusiopainotettua kuvaa. Eri kudokset rajoittavat vesimolekyylien diffuusiota eri tavoin, 
mikä tekee DWI-tekniikasta herkän kudosten rakenne-eroille. Toistaiseksi DWI-
tekniikan kliinisenä käyttökohteena ovat olleen erilaiset aivojen sairaudet. Menetelmällä 
on myös sovelluskohteita onkologiassa, erityisesti rintasyövän kuvantamisessa. Malig-
nien kasvaimien ADC arvot ovat yleensä matalampia kuin vastaavat benignien kas-
vaimien arvot. DW-kuvantamisella on monia etuja tavalliseen varjoaine-
magneettikuvantamiseen verrattuna: DWI on edullisempi ja nopeampi ja lisäksi se pa-
rantaa magneettikuvantamisen sensitiivisyyttä rintasyöpätyypin karakterisoinnissa. 
 Tämän diplomityön aineisto koostui 45 rintasyöpäpotilaasta, joilla oli yhteensä 
48 malignia ja 8 benigniä kasvainta. Työssä suoritettiin seuraavat kokeet: benignien ja 
malignien kasvaimien ADC-keskiarvojen vertailu, ADC-mittausten toistettavuus, sig-
naali-kohinasuhteen (SNR) ja ADC-arvojen välinen korrelaatio sekä kasvaimen koon 
vaikutus ADC-arvoihin. Tulosten tilastollista merkitsevyyttä analysoitiin SPSS-
ohjelmalla. 
 Benignien kasvaimien normalisoiduksi ADC-arvoksi saatiin 0.80±0.23 x10-3 
mm2/s ja malignien vastaavasti 0.63±0.20 x10-3 mm2/s ja ne todettiin eroavan tilastolli-
sesti merkittävästi toisistaan. Malignien kasvaimien raja-arvoksi määritettiin  
0.83 x10-3 mm2/s, jolloin sensitiivisyys oli 83.3% ja spesifisyys 37.3%. ADC-arvojen 
mittausmenetelmä osoitti eriomaista toistettavuutta (ICC 0.94), erityisesti suurien kas-
vaimien tapauksessa. ADC- ja SNR-arvojen välillä ei havaittu korrelaatiota. Tulokset 
olivat lupaavia, joten lisätutkimukset ovat perusteltuja. Esimerkiksi tutkimukset suu-
remmalla aineistolla ja eri rintasyöpätyyppien kanssa olisivat mielenkiintoisia. Tulevai-
suudessa malignien ja benignien kasvaimien ADC-raja-arvoa voidaan käyttää radiolo-
gien työkaluna rintasyövän karakterisoinnissa. 
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1. INTRODUCTION 
Magnetic resonance imaging (MRI) is one of the most important imaging modalities in 
today’s modern world. It has high contrast sensitivity to soft tissue differences and the 
use of nonionizing radiation makes it safe to use. MRI is based on nuclear magnetic 
moment of the hydrogen nuclei (protons). [1] When placed in high magnetic field pro-
tons align with parallel or antiparallel direction with the external magnetic field. Radiof-
requency fields are used to excite the protons and after the pulse is switched off the sys-
tem relaxes back to equilibrium state. When relaxing, protons are moving and moving 
charge generates a magnetic field. According to Faraday’s law of induction, this induc-
es a voltage that can be measured with MRI detectors. [2] 
New technological advances in MRI have made possible the detection of micro-
scopic diffusion of water molecules in extracellular space. This technique is called dif-
fusion-weighted magnetic resonance imaging, or diffusion-weighted imaging (DWI). 
The MRI sequence sensitive for motion of water molecules was introduced by Stejskal 
and Tanner already in 1965. [3] 
The level of diffusion in biological tissues is related to the tissue composition so 
it can be used as imaging contrast. With the obtained diffusion-weighted images (DW 
images) it is possible to generate diffusion constant maps, called ADC maps. ADC maps 
describe the strength of diffusion in tissues and they can be used to study abnormalities 
in tissue structures. DWI have been clinically used to detect brain disorders, like brain 
ischemia, but now also oncological applications are found potential. Breast cancer is 
one promising application for DW imaging. [3] 
 Breast cancer is the most common cancer type among women and it has come 
more and more frequent during last decades [4]. Cancer begins when cells in a part of 
the body start to grow out of control. In most cases the cancer cells form a tumor, which 
can be considered as malign or benign depending if it is cancerous or noncancerous, 
respectively. Malign changes are usually fast-growing lesions and they can spread to 
other parts of the body, which is called metastasis. Benign lesions instead do not invade 
into surrounding tissues nor form metastases. [5] Malign and benign changes can be 
further divided into subgroups. For example malign breast cancers can be into two main 
groups according to the appearance of growth: ductal and lobular carcinoma. [6] In this 
thesis the ductal carcinoma is studied. 
Breast imaging is needed for different purposes, for example in screening for 
breast cancer and classifying breast abnormalities. Mammography is the most applied 
breast imaging method. Other used methods are ultrasound and MRI, which are usually 
used as additional methods for mammography [6]. DWI has potential to improve the 
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sensitivity of MR imaging. The contrast imaging without added contrast material is saf-
er for patients and also cheaper and faster compared to DCE-MRI. [7] 
 This Master of Science Thesis is made at Tampere University of Technology at 
Biomedical Engineering Department. The clinical research is done at Tampere Univer-
sity Hospital. The purpose of this thesis is to measure and analyse ADC values of be-
nign and malign breast lesions. The ADC values are analysed through four different 
studies: comparison of mean ADC values of benign and malign lesions, repeatability of 
ADC measurements, correlation between ADC and signal-to-noise ratio values and ef-
fect of lesions size to ADC values. Results are analysed statistically with SPSS software. 
 Thesis begins with technical and medical backgrounds, after which the used ma-
terials and methods are explained. Next the results of studies are first introduced and 
then discussed. Also reliability and clinical applicability of the DWI as breast imaging 
method are discussed. Finally conclusion ends the thesis. 
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2. MAGNETIC RESONANCE IMAGING 
Magnetic resonance imaging (MRI) is a medical imaging technique based on the nucle-
ar magnetic resonance (NMR). The main signal source is nuclei of hydrogen atoms H1 , 
which are protons. NMR was invented already in 1920s but its medical potential was 
found in 1972 when Raymond Damadian measured MR signals from normal and tumor 
tissues of rats. The first MRI equipment prototype was developed in the University of 
Aberdeen (England) by Jim Hutchison, Bill Edelstein, and their colleagues. Nowadays 
MRI is widely used in hospitals for high resolution medical imaging. [8] 
The magnetic imaging system requires three different kinds of electromagnetic 
fields: constant magnetic field, radiofrequency (RF) pulses, and gradient fields. The 
constant strong magnetic field is usually obtained with superconducting magnets and 
common clinical field strength is from 1.5 to 3 T. RF pulses are needed to excite and 
detect the MR signal. Moreover, magnetic field gradients are needed to be able to local-
ize the MR signals in the body. These gradients are achieved by generating short-term 
spatial variations in magnetic fields strength across the patient. The gradient fields are 
needed in all three coordinate directions. [2; 9] 
2.1 Nuclear magnetic resonance 
The magnetic properties of the nuclei are described by the nuclear magnetic moment. 
The nuclear magnetic moment is generated by the protons and neutrons of the nucleus. 
If the number of protons, neutrons, or both is unpaired, the resultant noninteger spin 
generates a nuclear magnetic moment. Otherwise no net nuclear magnetic moment is 
observed. The nucleus of the hydrogen atom is composed of a single proton, which thus 
has a nonzero nuclear magnetic moment. Hydrogen is a good choice for clinical use in 
MRI because it has large magnetic moment, magnitudes of greater sensitivity compared 
to other elements and it has also great abundance in biological tissues. The nuclear 
magnetic moment of a single atom is not strong enough to be observed, but a large 
number of nonrandomly oriented nuclei generates a detectable nuclear magnetic mo-
ment, from which the MRI signals are derived. [2; 9] 
 Proton spins around its own axes, and thus the hydrogen nucleus is a continu-
ously rotating positive charge. The moving charge generates a magnetic field, so the 
proton can be considered as a tiny bar magnet. When placed in a strong magnetic 
field	, the proton tries to align itself parallel with the external field. However, the pro-
ton experiences a turning force, torque, which prevents the proton to align completely 
with the external field. This makes the proton to precess around the direction of the ex-
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ternal magnetic field (Fig. 1a). The precession occurs at an angular frequency  which 
is proportional to the external magnetic field B, given by the Larmor equation: 
 
  ,         (1) 
 
where  is the gyromagnetic ratio unique for each element. [2; 9] 
2.2 Magnetization 
When placed in external magnetic field B, some of the protons align in parallel and 
some in antiparallel direction with the field due to the magnetic forces (Fig. 1a). At 
equilibrium the occupation of the states is almost equal but a slight majority exist in the 
low energy level, which means the parallel direction with the applied field. Although 
the difference in the occupation of the two energy levels is quite small, it is enough to 
produce a detectable MRI signal. The vector sum of all the spins generates the net mag-
netization M, which is aligned with the external magnetic field B (Fig. 1b). The magnet-
ization vector M does not have a component in the perpendicular direction because the 
spins are randomly distributed over the surface of the cone, and thus sum to zero.  [2; 9] 
 
 
Figure 1. a) A single proton can precess about its axis in parallel or antiparallel direc-
tion with respect to the external magnetic field B.  b) A group of protons generates the 
net magnetization M. Figure modified from MRI From Picture to Proton [9]. 
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2.3 Image acquisition 
Magnetization M is the order of microtesla, so it is really small compared to the main 
magnetic field [9]. In order to get a measurable signal with MRI, the spins are excited 
with RF pulses oscillating at the Larmor frequency. 
2.3.1 Excitation 
The magnetization vector M can be tilted to the transverse plane using a RF pulse oscil-
lating at the Larmor frequency. This Larmor resonance frequency pulse excites protons 
from lower energy state (the parallel direction) to the higher energy state (the antiparal-
lel direction), and the magnetization vector z-axis component, the longitudinal magneti-
zation Mz along the direction of the main magnetic field, decreases. Respectively the 
transverse magnetization Mxy increases. M moves away from the z-axis until the RF 
pulse is switched off. With a 90° RF pulse the magnetization vector M can be turned to 
the xy-plane, and thus Mz reaches 0 value. (Fig 2) After this the magnetization will relax 
back to original state. [2; 10] 
 
 
Figure 2. a) In equilibrium the magnetization vector M is aligned with external magnet-
ic field B in z-direction. b) When 90° degree RF pulse is applied to the system, magneti-
zation vector M starts to move away from z-axis. Longitudinal magnetization Mz pre-
sents the z-component of the magnetization vector M and respectively transverse mag-
netization Mxy describes the magnetization vector’s component in xy-plane. c) 90° RF 
pulse will turn the magnetization vector M into the xy-plane. 
2.3.2 Relaxation 
An applied RF pulse creates a non-equilibrium state by adding energy to the system and 
so after the pulse is switched off the system relaxes back to the thermal equilibrium. 
There are two principal relaxation processes: spin-lattice (T1) and spin-spin (T2) relaxa-
tions. These can be described mathematically with set of differential equations which 
are called Bloch equations. [9; 10] 
 Spin-lattice relaxation T1, also called as longitudinal relaxation, describes the 
rate of recovery of the longitudinal magnetization Mz towards the equilibrium after the 
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RF pulse has been switched off. T1 describes the time needed for 63% (1-(1/e)) recov-
ery. The recovery of magnetization as a function of time is described as follows: 
 
 
  
 1  
    
0
  ,     (2) 
 
where 
	is the equilibrium magnetization.  
Spin-spin relaxation, also called as transverse relaxation T2, instead describes 
the dephasing of spins, which leads to signal decay. Elapsed time between the peak 
transverse signal and 37% (1/e) of the peak level is the T2 relaxation time. Mathemati-
cally this is described as: 
 

  
0
 
 .       (3) 
 
Different tissues have different values for T1 and T2 time constants and thus different 
recoveries, which gives rise to contrast in MR images. In Figure 3 the equations (2) and 
(3) are plotted against time. [10; 11] 
 
 
Figure 3. a) After 90° pulse the longitudinal magnetization Mz will return to equilibri-
um exponentially. At t=T1 the longitudinal magnetization Mz has recovered by factor 1-
(1/e). b) The loss of transverse magnetization Mxy phase coherence occurs exponentially 
caused by intrinsic spin-spin interactions. At t=T2 the signal has decayed to 1/e of the 
initial transverse magnetization.  
 
When a RF pulse is applied to the system, magnetization vector rotates into the trans-
verse plane. In the transverse plane the precessing magnetization will generate a time-
varying magnetic flux. According to Faraday’s law of induction, this flux induces a 
voltage that can be measured with MRI detectors. The amplitude of the signal decays 
exponentially to zero rapidly, because the protons dephase with respect to each other. 
This decay signal is called Free Induction Decay (FID). However, FID is not used to 
generate MR images, instead different kinds of pulse sequences are used in clinical 
scans. [9; 10] 
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2.4 Pulse sequences 
The RF pulse sequences applied to the system are called pulse sequences. There are two 
common pulse types used in clinical use: spin echo (SE) and gradient echo (GE) se-
quences. In DWI a modified SE sequence, pulsed gradient spin echo (PGSE) sequence 
is used. 
2.4.1 Spin Echo Sequence 
SE sequence uses two RF pulses: 90° pulse and 180° pulse. The 90° pulse is used to 
excite the system. It converts the magnetization vector M into xy-plane, like presented 
in Figure 2. The transverse magnetization Mxy starts immediately decay because the 
spins start to get out of phase. Next the second 180° pulse is applied. It will invert the 
spins and they start to move back into phase coherence. The time between the beginning 
of 90° pulse and the phase coherence is called time of echo (TE). In addition, the time 
between the new RF pulse sequence is called the time of repetition (TR). During the TR 
interval, T2 decay and T1 recovery occur in tissues. TR value range from extremely 
short (millisecond) to extremely long (tens of seconds). [2] 
2.4.2 Gradient Echo Sequence 
GE sequence uses only a single RF pulse, a 90° pulse. After the 90° pulse the spins start 
to diphase and simultaneously the magnetic field gradient is applied. After time TE/2, 
the reversal gradient is applied causing the rephrase of spins. This produces the gradient 
echo. [2] 
2.4.3 Pulsed Gradient Spin Echo Sequence 
In the case of diffusion weighted imaging, the often used imaging sequence is called 
pulsed gradient spin echo (PGSE), sometimes called Stejskal and Tanner method after 
its inventors. It is similar to SE sequence but two additional gradient pulses are applied 
symmetrically around 180° pulse. After the 90° RF pulse the first gradient lobe is ap-
plied and as a consequence the spins evolve freely. Statistic spins stand still while the 
moving spins change their relative position. Like in SE sequence, a 180° pulse is acti-
vated to refocus the spins. Finally, a second gradient lobe, of the same intensity as the 
first one, is applied. Static spins now remain the same situation as before the sequence. 
The moving spins instead do not recover the phase after the second gradient pulse be-
cause they have changed their position between both gradient lobes. The contrast in 
diffusion images arises from the fact that the signal from the average moving spins is 
lower than the one form the static spins. Schematic presentation of PGSE sequence is 
presented in Figure 4. [3; 9] 
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Figure 4. Schematic presentation of PGSE sequence. Two identical diffusion gradient 
pulses are inserted before and after a 180° pulse. Factors defining the degree of diffu-
sion are the gradient amplitude G, duration	, and the time between the two gradients	Δ. 
Figure modified from [7]. 
2.5 Diffusion  
Diffusion is a phenomenon in which molecules over 0 K temperature experiment a 
Brownian motion caused by thermal energy and in consequence molecules from a re-
gion of higher concentration will move to a region of lower concentration. Diffusion can 
be modelled from a molecule point of view with random walk model, which considers 
movement of a single molecule and generalizes it into experimentally measurable varia-
bles, like diffusion constant. Another approach is to study diffusion from concentration 
gradient point of view with Fick’s law.  
2.5.1 Random walk 
Brownian motion of a single particle can be modelled with random walk. In this model 
particle takes N steps of length L to random directions. The mean displacement r of a 
random walk is zero, but the square of the displacement has a nonzero average r2, which 
is: 
  ! "	 #$!.       (4) 
 
If the particle takes a step in every time interval	Δ, after total time t the particle has 
taken #  /Δ random steps. When defining the diffusion constant as: 
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the mean-square displacement in a random walk becomes: 
 
    ! ) ('*       (6) 
 
which is also called the diffusion law. Diffusion constant D describes the intensity of the 
diffusion. From equation (6) can be seen that the mean-square displacement increases 
with time and with higher diffusion constant. So if molecules are let move longer time 
they will move further and if diffusion is strong molecules will also move further. 
Diffusion is an event of random fluctuations. Random collisions also give rise to 
friction, which in case of fluids can be described with viscous friction coefficient	+. For 
a spherical object the viscous friction coefficient is expressed with Stokes formula: 
 
  +  ,-./,        (7) 
 
where . is the viscosity of the fluid and R is the radius of the particle. Einstein connect-
ed friction with diffusion with following formula: 
 
+'  012,        (8) 
 
where 01 is Boltzmann constant, T is temperature and + is the viscous friction coeffi-
cient. This Einstein relation shows that diffusion depends also on temperature and size 
of the particles; diffusion is greater in higher temperatures but high viscosity or big par-
ticles decrease diffusion. [12] 
2.5.2 Fick’s law 
Random walk is a practical and simple model for diffusion of individual particles but 
when considering diffusion of larger amount of particles, like ink molecules in a glass 
of water, something more universal is needed to describe the diffusion process. One 
way is to study concentration profiles. Concentration differences create particle flux, 
which can be described with Fick’s law (in one dimension): 
 
   3  ' 454,         (9) 
 
where j is the particle flux and c  is the concentration. The intensity of flux describes the 
diffusion, thus the diffusion is greater with higher concentration gradient. [12] When 
considering the continuity equation dc/dt = - dj/dx, equation (9) can be further devel-
oped to the diffusion equation: 
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2.5.3 Diffusion types 
Diffusion can be divided into three main types: free, isotropic and anisotropic diffusion. 
Free diffusion means movement of water molecules in environment with no obstacles. 
For example molecules in glass of water will diffuse freely through Brownian motion. 
[12; 13] Instead in isotopic diffusion the average distance of displacement of water mol-
ecules is the same in all directions. The difference to free diffusion is in the slight re-
striction of displacement due to for example cell membranes. Diffusion in biological 
tissues can often be considered as isotropic. [1; 13] In the case of anisotropic diffusion 
the movement of molecules is restricted in only certain spatial directions. For example 
in brain structures water molecules diffuse faster in the direction of axons than perpen-
dicular to the axons. [1] Schematic presentation of different types is presented in Figure 
5. 
 
 
Figure 5. Schematic presentation of different diffusion types, modified from [13]. a) 
Free diffusion allows molecules to diffuse freely in all directions. b) In isotropic diffu-
sion e.g. cells restrict diffusion but it is allowed in all directions. c) Anisotropic diffu-
sion restricts movement in certain directions. 
2.6 Diffusion-Weighted MRI 
Diffusion-Weighted MRI (or diffusion-weighted imaging, DWI) is a medical imaging 
technique based on motion of water molecules. The MRI sequence sensitive to Browni-
an motion was introduced by Stejskal and Tanner already in 1965. [3] This sequence is 
described in chapter 2.4.3.   
The DW images are produced by sensitizing the system with gradient pulses 
from different directions. The gradient strength can be described with b-values. With 
DW images obtained with multiple b-values from three orthogonal direction it is possi-
ble to produce ADC maps, which describe the strength of diffusion in tissues. However, 
to obtain information about the direction of diffusion, at least six diffusion gradient di-
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rections are needed. This kind of direction diffusion imaging is called diffusion tensor 
imaging (DTI). [14; 15] 
2.6.1 b-value 
A b-value is a constant describing the gradient strength or the diffusion weighting 
achieved. It quantifies the amount of signal loss to be expected with a given pulse se-
quence for a given diffusion constant. [1; 16] b-value is proportional to the square of the 
gradient strength G in the following matter: 
 
)
3
(222 δδγ −∆= Gb ,        (11) 
 
where γ is the gyromagnetic constant, δ represents gradient pulse duration, and ∆ repre-
sents the separation between applied gradient lobes. Thus b value has units of s/mm2. [3; 
9] 
2.6.2 ADC maps 
The diffusion constant can be measured by performing multiple MRI scannings with 
different b-values. At least two different b-values are needed, but the accuracy may be 
improved through a greater number of b-values. The obtained diffusion constants are 
called as apparent diffusion coefficients (ADC), to differentiate them from the constant 
of diffusion in pure water (equation 5). [1] ADC using two b-values is determined as 
follows: 
 
01
10 )/ln(
bb
SSADC
−
= ,         (12)  
 
where bi stands for the b-values and corresponding Si intensities on the diffusion-
weighted image. Images whose gray-scale values represent the mean ADCs of the cor-
responding voxels are known as ADC maps. [17] 
Diffusion weighting depends on the applied diffusion direction. To obtain iso-
tropic image, three orthogonal diffusion direction are needed to combine an ADC map. 
This isotropic image represents the effect of the average water movement in an isotropic 
tissue independently of the diffusion directions applied. [3] The direction dependent 
DW method, DTI is described in next chapter. 
DW images describe the actual diffusion in tissues while the ADC maps tell the 
difference between two DW images. If water molecules can move relatively freely in 
tissues, they show lower pixel intensity Si in DV images. This is because water mole-
cules can be considered to “move out of the pixel”. On the other hand in the ADC map 
the difference to the original situation is high, which implicates that the ADC pixel val-
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ue is also high. And vice versa, for high DW image intensity, the ADC values are lower. 
[18] This reasoning is presented schematically in Figure 6. 
 
 
 
Figure 6. Relationship between molecule diffusion and image intensity in diffusion-
weighted image and ADC map. 
2.6.3 Diffusion Tensor Imaging 
In anisotropic tissues the diffusion constant depends on the direction of applied diffu-
sion gradients. A diffusion imaging where multiple directions are measured is known as 
diffusion tensor imaging (DTI). Now the diffusion properties of the tissues are described 
with a three-dimensional diffusion tensor D : 
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where in each Dij the first subscript refers to tissue orientation and the second refers to 
the gradient orientation. The diagonal elements Dxx, Dyy and Dzz, correspond to three 
orthogonal direction, which are used also in determination of scalar ADC values. [9; 19] 
 Diffusion tensor D as such is not ideal form to visualize the diffusion. Further 
processed way is to visualize diffusion with scalar parametric maps, like mean diffusivi-
ty (MD) and fractional anisotropy (FA). [14] MD presents the strength of diffusion by 
means of eigenvalues 1λ , 2λ , and  3λ : 
 
3
321 λλλ ++
=MD .        (14) 
 
FA instead shows the degree of anisotropy in tissues. It is described with following 
formula: 
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where iλ is the eigenvalue and MD the mean diffusivity (equation 14). The values of FA 
range from 0 (completely isotropic) to 1 (completely anisotropic).  [3]  
2.6.4 Potential clinical applications of DWI 
DWI has potential applications especially in oncology, because tumor tissues have dif-
ferent cellularity compared to normal tissue. Cancerous tissues restrict water diffusion 
of water molecules more than normal tissues and thus have lower ADC values than 
normal tissue. Different review articles [17; 20] suggest that DWI could be used for 
example in tumor detection, tumor characterization, monitoring treatment response, and 
predicting treatment response. Possible application targets could be for instance liver, 
pancreas, kidney, breast and prostate cancers. Even whole body diffusion imaging is 
studied. However, its main limitation are the sensitivity to motion influences, like cardi-
ac and respiratory movements.  [3; 17] 
The directionality information of DTI can be best utilized in studying brain tis-
sues. For example cerebral ischemia, epilepsy or brain tumors can be diagnosed with 
DTI. In many brain disorders the early diagnosis is crucial and DTI has great advantage 
in information from cellular level when compared to traditional imaging methods like 
CT and MRI. [9; 21] 
  
 
14 
 
 
3. BREAST CANCER 
Breast cancer is the most common cancer type among women. Only lung cancer causes 
more cancer-related deaths in women. Breast cancer has become more and more fre-
quent during last decades: in Finland in 2011 there were 4865 new cases. Breast cancer 
frequency increases substantially among the women after the age of 45 and the average 
age for diagnosis is at the age of 60. Breast cancer is diagnosed also for the women un-
der the age of 30 but in this age group it is rare. [6] 
3.1 Normal Breast 
In humans, paired mammary glands rest on the pectoralis muscle on the upper chest 
wall. The female breast consists mainly of lobules, ducts and stroma. Stroma is connec-
tive tissue that surrounds the ducts and lobules. [4; 22] There are usually six to ten ma-
jor ducts which branch further into smaller ones. Eventually the terminal duct branches 
into a grapelike cluster of small acini to form a lobule. Lobules are the milk producing 
glands that are modified sweat glands. (Fig. 7) [22-24] 
 
 
Figure 7. Female breast structure, "Breast anatomy normal scheme" by Original author: 
Patrick J. Lynch. The arrows show 1. chest wall, 2. pectoralis muscles 3. lobules 4. nip-
ple 5. areola 6. milk duct 7. fatty tissue and 8. skin. [25] 
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3.2 Breast tissue changes 
Breast tissue changes, or breast lesions can be divided into two groups: benign and ma-
lign lesions. Malign lesions, or cancerous tumours, are fast-growing lesions. They can 
grow invasively into the surrounding tissues or spread to other parts of the body, which 
is called metastasis. Malign tumours are often fatal because of the invasive nature and 
the ability to form metastases. [5]  
Benign lesions instead are not cancerous. They are typically slow-growing and 
can be well distinguished from the surrounding tissue. Benign lesions do not invade into 
other tissues and they do not form metastases. Benign lesion cells resemble the normal 
tissue cells both in structure and in functional features. Usually benign tumours are not 
life threatening. Separation between malignant and benign tumors is made through a 
histo-pathological study. [4; 5] 
3.2.1 Benign Lesions  
The majority of breast abnormalities are benign. They can be classified into three 
groups according to later risk of developing breast cancer: Nonproliferative breast 
changes, proliferative breast changes and atypical hyperplasia.  Only certain way to 
distinguish benign lesions from malignancy is biopsy and histologic examinations. [23; 
24; 26] 
Nonproliferative breast changes 
Nonproliferative changes (also called fibrocystic changes) are not associated with a risk 
of breast cancer. They are most common group of disorders of the breast for women 
between ages 20 and 40 [23; 24]. Typical histological features of fibrocystic changes 
include for example cysts, expansion of lobules, and stromal fibrosis. The cause of these 
changes is not clear and it is thought to be related to a localized imbalance between es-
trogen and progesterone. [23] 
Proliferative breast changes and atypical hyperplasia 
Proliferative changes are associated with small increase in the risk of later carcinoma. 
Lesions are characterized with proliferation of epithelial cells but they are not clonal 
and are not commonly found to have genetic changes. There are different types of pro-
liferative changes, e.g. epithelial hyperplasia, sclerosing adenosis, and papilloma. [24] 
  Atypical hyperplasia is associated with increased risk of carcinoma. It includes 
two forms: atypical ductal hyperplasia and atypical lobular hyperplasia. These atypical 
hyperplasia have histologic resemblance to carcinoma in situ (described later). [24] 
3.2.2 Malignant lesions 
There are several types of breast cancer, which can be divided into two main groups: in 
situ carcinomas and invasive carcinomas. In the case of carcinoma in situ the tumor has 
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limited to ducts and lobules by the basement membrane. Invasive carcinoma instead has 
penetrated through the basement membrane into the stroma. These two main groups 
divide into numerous sub types. In this chapter the most common types are introduced. 
[24] 
Carcinoma in situ 
Carcinoma in situ can also be called as non-invasive or pre-invasive carcinoma due to 
its possibility to develop into invasive carcinoma if left untreated [4; 26]. There are two 
types of in situ carcinomas: ductal carcinoma in situ and lobular carcinoma in situ. 
These both types usually arise from cells in the terminal duct lobular unit. [26] 
 
Ductal carcinoma in situ 
Ductal carcinoma in situ (DCIS) is an intraductal lesion limited to ducts and lobules 
with no evidence of invasions through basement membrane into surrounding stroma. 
Hence, DCSI can be considered a pre-cancer because some cases can develop and be-
come invasive carcinoma. [4; 23; 24] Due to mammographic screening, the DCIS cases 
are found more easily. Nowadays 15-30 % of all breast carcinomas are diagnosed as 
DCIS in Finland whereas before the screening the portion was only 5 %. [5]  
 
Lobular carcinoma in situ 
Lobular carcinoma in situ (LCIS) can be considered as preliminary stage for invasive 
lobular carcinoma as the cells of LCIS are identical with the cells of invasive carcinoma 
and they share genetic abnormalities [24]. Cancerous cells fill the lumen of lobules and 
LCIS usually expands but does not alter the acini of lobules [5; 26]. LCIS lesions can-
not be found with mammography since they are not associated with calcifications or 
stromal reactions that produce mammographic densities [24]. Therefore LCIS if pretty 
rare: in Finland only 1-6% of all breast cancers are diagnosed as LCIS. Approximately 
25% of patients diagnosed with LCIS will develop invasive carcinoma in 25 years. [5] 
Invasive carcinoma 
An invasive cancer is carcinoma that has already grown beyond the basement mem-
brane. Most breast cancers are invasive carcinomas. Here the most common ones, inva-
sive ductal carcinoma and invasive lobular carcinoma, are presented. [4; 24] 
 
Invasive ductal carcinoma 
Invasive ductal carcinoma (IDC) is the most common type of breast cancer: in Finland 
70 % of the breast cancers are IDC [4; 6]. This type of cancer is often associated with 
DCIS and rarely with LCIS. [26] IDC begins like DCIS but breaks through the base-
ment membrane and grows into the stroma. It produces a desmoplastic response, which 
replaces normal breast fat and forms a hard, palpable mass [26]. IDC can also metasta-
size to other parts of the body through the lymphatic system. [4] 
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Invasive lobular carcinoma 
Invasive lobular carcinoma (ILC) is second common breast cancer type in Finland: 10-
20% of all breast carcinoma cases [6]. In the case of ILC, cancerous cells invade indi-
vidually into stroma and are often aligned in "single-file" strands or chains. This is why 
ILC may be harder to detect by a mammogram than IDC. [4; 26] Like IDC, lobular car-
cinomas can also metastasize to other parts of the body; they more frequently spread to 
cerebrospinal fluid, serosal surfaces, gastrointestinal tract, ovary, uterus, and bone mar-
row. Lobular carcinomas also are more frequently multi-centric and bilateral. [4; 26]  
3.3 Breast Cancer Imaging Methods 
Breast imaging is needed in different breast imaging areas, for example in screening for 
breast cancer and classifying breast abnormalities. In this chapter the common breast 
imaging method are presented briefly and discussed when and why they are used in 
breast imaging. After this new potential breast imaging method, diffusion-weighted im-
aging, is introduced and its contribution is estimated. Eventually different methods are 
compared. 
3.3.1 Mammography 
Mammography is the most used technique for breast cancer detection. It is a low-dose 
x-ray system designed especially for imaging breasts. [27] In mammography imaging 
the breast is compressed with plastic plate to obtain better quality images. Images are 
taken usually from at least two direction: craniocaudal and mediolateral projections 
[28]. Mammography is used both in screening and diagnosis of breast cancer. [29] 
The screening mammography is performed among asymptomatic women with-
out a personal history of breast cancer. [29] In Finland women of ages 50-69 are 
screened every second years [30]. Goal of the mammographic screening is to find breast 
carcinomas as early as possible, before they cause any symptoms or palpable masses. 
[28; 29] Tumors found with screening are usually less than 1 cm in diameter [28]. The 
size of a tumor and how far it has spread are important factors in predicting the progno-
sis for a patient. [4] If an abnormality is found in screening mammography, additional 
imaging is needed. This can be done with diagnostic mammography. Imaging direction 
vary according to each study. [29] 
3.3.2 Ultrasound 
Ultrasound (US) is widely used breast examination method, which applies ultrasound 
waves and acoustic properties of the body to produce medical images. [28] Ultrasound 
represents the sound waves with frequency above 20 kHz. Medical ultrasound uses fre-
quencies starting from 2 MHz up to 20 MHz, with special ultrasound applications up to 
18 
 
 
50 MHz. Ultrasound is produced and detected with a transducer. It converts the electri-
cal energy into mechanical energy to produce ultrasound and mechanical energy back to 
electrical energy for ultrasound detection. [2] 
In breast cancer examination US is operated along with mammography. It is 
usually used as further study for mammographic finding, for example to distinguish 
cysts and solid masses. [4; 28] Moreover, US can be used to image palpable mass in 
dense breast tissue.  Especially among young women the breast tissue is dense and thus 
contrast in mammography might be poor. [28] 
3.3.3 Magnetic Resonance Imaging 
MRI technique is discussed in detail in the Chapter 2. In breast cancer examination con-
trast-enhanced MRI (DCE-MRI) is used, like US, in further studies for masses found in 
mammography. It is also used for screening of women at high risk for development of 
breast cancer. [4; 6] According to American Cancer Society, this includes women who 
have a known BRCA1 or BRCA2 gene mutation or who have first-degree relative with 
these gene mutations but are themselves untested. Annual screening is also recommend-
ed for women with 20-25% or greater lifetime risk of cancer development based on 
family history and for women who have received radiation therapy to the chest between 
ages of 10 and 30. Furthermore, women with Li-Fraumeni syndrome, Cowden syn-
drome, or Bannayan-Riley-Ruvalcaba syndrome, or first-degree relatives with one of 
these syndromes are recommended to have MRI screening in addition to mammograph-
ic examination. [4] 
3.3.4 Diffusion-Weighted Imaging 
Diffusion weighted imaging (DWI) is a MRI technique that measures the mobility of 
water molecules, described in detail in chapter 2.6. The contrast in DWI arises from the 
changes of water mobility in different tissues. Since the tissue properties differ between 
benign and malign lesions, DWI imaging can be used for lesions type differentiation. 
[31; 32] 
Tissue properties and ADC values 
 The degree of motion measured by DWI relates to the mean path length trav-
elled by water molecules in the tissue within specific observation time period. In biolog-
ical tissues the motion is restricted by intracellular and extracellular compartments, and 
macromolecules. In tissues with low cell density the mean path length travelled by wa-
ter molecules is much greater than in tissues with high cell density (Figure 8). Thus the 
degree of water diffusion in biological tissues is inversely correlated with the tissue cel-
lularity. [7; 33] 
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Figure 8. Schematic presentation of how the cellularity of tissue affects the distance 
traveled by water molecules in extracellular space. a) In high cellularity tissue the mean 
path length (red line) travelled by water molecules is shorter than in b) low cellularity 
tissue. So the degree of water diffusion in biological tissues is inversely correlated with 
the tissue cellularity. Figure modified from [7].  
 
Breast tumors typically have high cellular density, thus the diffusion of water 
molecules is more restricted in malignant tissue than in benign lesions or normal breast 
tissue. Like described earlier in chapter 2.5.2, restricted diffusion indicates high signal 
intensity on diffusion-weighted images and further low ADC values. By contrast, be-
nign lesions usually exhibit low intensities in DW images and higher ADC values. 
However, the differentiation is not so straight forward due to overlapping of malign and 
benign lesion ADC values. For example DW imaging of DCIS is controversial: De-
pending on whether DCIS appears mass-forming or low cellularity form its DW image 
intensity differs. Consequently, most of the false-negative cases reported at DWI of 
breast represents DCIS. [7; 18] In addition, in the case of benign changes the signal in-
tensity may be influenced by used b-value [18].  ADC values for benign and malign 
lesions can be found widely in literature. The ADC values for normal breast tissue are 
about 1.51-1.91 x10-3 mm2/s for b-values 0 and 1000 s/mm2 [34; 35]. Summary of meas-
urement results from different studies are combined into Table 1. 
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Table 1. ADC values of benign and malign lesions from various studies. [34-43] 
Study b-values (s/mm2) 
Benign Malign 
ADC 
(10-3 mm2/s) N 
ADC 
(10-3 mm2/s) N 
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Imaging protocol optimization 
ADC values of lesions depend on used b-values. With low b-values the diffusion 
weighting effect is weaker and thus also perfusion effects are strongly present in DW 
images. Instead at higher b-values, the diffusion effects are stronger than perfusion so 
DW images are mainly based on diffusion effects, like can be seen in Figure 9. ADC 
values are larger with low b-values and vice versa. Because of this the measured ADC 
values are comparable only with studies acquired with same b-values. [44] 
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Figure 9. Effect of different b-values (unit s/mm2) to DW images. In low b value imag-
es the veins can be seen clearly due to perfusion. Instead in high b value images the dif-
fusion effects are stronger.  
 
  The choice of b-values depends on the imaging application. In breast imaging 
the optimal b-values should give good contrast for lesions and normal breast tissue. To 
minimize the perfusion effects higher b-values are favored but on the other hand they 
also decrease the signal-to-noise ratio. Many studies [7; 18; 35; 45] indicate that b-
values between 800-1500 s/mm2 give best contrast. Like discussed in chapter 2.6.2 the 
accuracy of ADC map may be improved with the use of multiple b-values. However, 
studies of multiple b-values [44; 46] found no improvement over two b-value acquisi-
tions. Thus in clinical practiced DW imaging with two b-values is reasonable for time 
saving. 
 Diffusion-weighted imaging of breasts is technically challenging for several 
reason: tissue-air interfaces at skin surface and at thorax give rise to susceptibility arte-
facts and high fat tissue content causes image artefacts such as ghosting and chemical 
shift. The optimal fat suppression technique and good shimming are therefore essential 
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for high-quality DW imaging of the breast. Shimming is used to decrease magnetic field 
inhomogeneities. Improved shimming, or a higher magnetic field strength, allows better 
spectral separation of water and fat resonances, and thus better fat suppression. [7; 18] 
  Contrast between tumor and normal breast tissue in ADC-maps may not be as 
significant without appropriate fat suppression. There are two common ways for fat 
suppression in breast DWI: spectral fat suppression and inversion recovery. They both 
have their advantages and disadvantages but in general spectral fat suppression is pre-
ferred [7]. In addition to different technical tasks patient positioning is crucial for image 
quality. For example skin folds may cause inhomogeneous fat suppression. Also cosy 
position avoids unnecessary moving of patient during imaging. Patient motion between 
different diffusion-gradient images causes misregistration and further errors in ADC 
calculations. [7; 18] The imaging parameters for optimal imaging discussed above are 
combined in Table 2. Also some other parameters are listed based on articles of R. 
Woodhams et al. [18] and S.C. Partidge and E.S. McDonald [7]. 
 
Table 2. Imaging parameters for example diffusion-weighted imaging protocol. [7; 18] 
Parameter Specification 
Imaging sequence Spin-echo echo-planar imaging 
b-value 0, 800-1000 s/mm2 
Fat suppression Spectral fat suppression 
Slice thickness 4-5 mm 
Imaging time 4-6 min 
3.3.5 Comparison of Imaging Methods 
Mammography can be considered as the conventional breast imaging method at the 
moment. Because of this, it is widely available and also cheap imaging method. [4; 6] 
Even relatively small lesions are visible in mammography but its sensitivity varies 
widely (35-95 %) depending the structure of breast tissue [6]. Poorest sensitivity occurs 
with young women whose breast tissue is often dense and contains only little fat. Dense 
breast tissue is a major limitation of mammography. [6; 47]  
Ultrasound is cheap, nonionizing, and widely available imaging method. [4] 
Breast imaging study by Kolb et al. [48] compared the sensitivity of mammography to 
US with different density categories. With highest density level the sensitivity of mam-
mography was found 47.8% and of US 76.1%. Also other studies combined in review 
article [47] by P. K. Ravert et al. show an increase in the diagnostics of breast cancer by 
US in women with dense breast. However, US is not accurate method to detect small 
lesions (less than 1 cm in diameter). Thus it is not suitable for screening method of 
breast cancer but important as an additional method for mammography. [4; 28] New 
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ultrasound devices are capable of measuring lesions as small as 1-2 mm in diameter, 
which makes US important additional imaging method for mammography [27].  
MRI provides sensitive imaging with high accuracy, especially DCE-MRI tech-
nique. Its sensitivity and specificity are far better than with mammography and US, sen-
sitivity even 70-90% with young women [6]. However, it also has a higher false-
positive rate and its usability is limited in the detection of calcifications. Moreover, the 
disadvantages of MRI compared to mammography and US are the long scan times, usu-
ally 20 to 30 min, and the need for contrast medium. In addition, the contrast material 
increases the cost and is not suitable for all. Also claustrophobic persons are not com-
fortable with MR imaging. [4; 6; 29; 43] 
Like discussed in previous chapter DW-MRI has potential for improve the sensi-
tivity of traditional MRI. Thus false-positive rates could be reduced and unnecessary 
biopsies avoided. The contrast imaging without added contrast material is better for 
patients and also cheaper and faster. However, more research is needed before wide 
clinical use. [7; 18] The advantages and disadvantages of different methods are collect-
ed into Table 3. Also future prospects of the methods are estimated. 
 
Table 3. Advantages and disadvantages of different breast imaging methods combined: 
mammography (MG), ultrasound (US), magnetic-resonance imaging (MRI) and diffu-
sion-weighted magnetic resonance imaging (DW-MRI). 
Method Pros Cons Future 
MG 
o cheap 
o widely  
available 
o long traditions in 
breast imaging 
o low sensitivity 
with dense breast 
o stays as prime breast 
imaging method 
US 
o cheap 
o widely available 
o nonionizing 
o not accurate for 
small lesions 
o Additional method for 
mammography 
MRI 
o good resolution 
o high sensitivity  
o high specificity 
o nonionizing 
o expensive 
o time consuming 
o not suitable for 
claustrophobic per-
sons 
o additional imaging for 
mammography 
o screening for women 
with high breast cancer 
risk 
 
DW-
MRI 
o cheaper and faster 
than DCE-MRI 
o more sensitive 
than DCE-MRI 
o nonionizing 
o more research need-
ed before clinical use 
o availability 
o Instead of DCE-MRI 
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4. MATERIALS AND METHODS 
Materials used in this project were imaged in Turku University Hospital with Siemens 
Avanto 1.5 T device. Four different studies were carried out using DW image and con-
trast-enhanced MR image (DCE-image) series: Comparison of mean ADC values of 
benign and malign lesions, repeatability of ADC measurements, correlation between 
SNR and ADC values, and effect of lesion size to ADC values. In this chapter the used 
data and imaging parameters are introduced. Moreover, the steps used in measurement, 
calculations, and statistical analysis with SPSS software are explained.  
 
4.1 Subjects 
Data of the study included originally MR images of 50 patients collected in Turku Uni-
versity Hospital during February 2011 and February 2013 by doctors Ilkka Koskivuo 
and Nina Brück. From these two patients were excluded due to different imaging device 
and three patients due to failed fat suppression on the images.  Therefore the research 
was performed for 45 patients with age differing between 45 and 83 years, with average 
age of 60 years. Patients had altogether 48 malignant lesions, 5 malign suspects and 8 
benign lesions. All the carcinomas were ductal carcinoma in situ. Data characteristics 
are gathered into Table 4. 
 
Table 4. Details of data. 
Lesion type Number  
of lesions 
Area range 
(cm2) 
Mean area 
(cm2) 
Malign 48 0.14 - 1.53 0.56 
Malign suspect 5 0.17 - 0.46 0.29 
Benign 8 0.14 - 0.57 0.34 
4.2 MRI acquisition 
Siemens Avanto 1.5 T device was used for imaging. MRI was performed using T2-
weighted, DWI, and T1-weighted imaging sequences. T2-weighted imaging  was done 
with imaging parameters of: 39 slices with a field of view (FoV) 360 mm, a slice thick-
ness of 3.0 mm and voxel size 0.9x0.7x3.0 mm. SPAIR fat-suppressed DW imaging was 
performed with b-values of 0, 50, 500 and 1500 s/mm2 with 3 diffusion directions. Oth-
er parameters were: 30 slices with a FOV of 360 mm, a slice thickness of 5.0 mm and 
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voxel size 2.4x1.9x5.0 mm. T1-weighted contrast-enhanced imaging sequence was per-
formed after DWI sequence with following parameters: slice thickness 1.00 mm, FoV 
360 mm and voxel size 1.1x0.8x1.0 mm. 
4.3 ADC measurements 
Two different ADC measurements were performed: Measurement of ADC values of 
benign and malign lesions, and repeatability measurements. First step in the studies was 
to measure ADC values from the ADC maps with SyngoMMWP VE 36A –program. 
After this the needed calculations were performed to obtain wanted results.  
4.3.1 Benign and malign lesions 
Diffusion values for benign and malign lesions were measured by selecting the region 
of interest (ROI) in ADC map. The measurement were done by MP with no previous 
experiment from medical image viewing. The measurement procedure was as follows: 
 
1. Lesion as localised in contrast-enhanced MR image (DCE-image). Its coordi-
nates and size were measured with image program tools. 
2. The corresponding lesion location was searched in ADC map with the help of 
the obtained coordinates and ROI as drawn with the circular drawing tool. It 
as important to include a homogenous area inside the circle, i.e. exclude all 
boundaries and other dissimilar areas. The size of the ROI was maximized but 
yet limited to the size measured in DCE-image. Values of mean, standard de-
viation and area were wrote down. 
3. In order to be able to compare results between patients, it was necessary to 
normalize the results. For this reason, background noise and two reference 
points from surrounding tissue were measured.  
I. First reference point was drawn with circular tool into high intensity 
area. The size of this ROI is 1 cm2.  
II. The second reference point as drawn into homogenous tissue. Ho-
mogeneity could also be verified in DCE-image. Often these kind of 
areas had low intensity. This ROI was also 1 cm2 in size. 
III. Noise level was determined from background of the image, i.e. out-
side the patient. This ROI as drawn as 10 cm2.  
Reference point are drawn closest to 2-3 cm to the actual lesion. Reference 
points can be also measured from the other breast or from other slice than the 
actual lesion. 
 
Often lesion could be clearly seen also in the ADC image but sometime, especially with 
small lesions, the coordinates obtained from DCE-MR images were used as guidance. 
An example of ADC measurement is shown in Figure 10. 
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Figure 10. Example of ADC measurement. a) First lesions was localized in DCE-MR 
image (now shown with white arrow) and b) with the help of obtained coordinates its 
corresponding location was searched in ADC maps. c) ADC map could be visualized 
from three directions, sagittal, coronal and transverse. d) The ROI was drawn carefully 
into the lesion. e) Three reference ROIs were drawn into high intensity area, homoge-
nous tissue area and into the background (outside the patient). 
4.3.2 Repeatability  
The reliability of ADC measurements was tested with repeated measurements. The 
measurements were performed for 16 randomly chosen malign lesions by same measur-
er (MP) seven month later than first ADC measurements. Measurements were per-
formed like described in previous chapter (4.3.1). The repeatability was evaluated 
through intra-class correlation (ICC) values. 
27 
 
 
4.4 Signal-to-Noise ratio and lesions size measurements 
Signal-to-Noise ratio (SNR) and lesion size measurements were performed to study the 
correlation between them and ADC values. 
4.4.1 Signal-to-Noise Ratio 
When determining the noise levels of images, the diffusion values for lesions and back-
ground were measured from DW images. The DW images with b=0 s/mm2 were used 
for this measurement.  Lesion position was searched in DW image. If necessary, DCE-
MR image was used to check the location. Using circular tool, ROI was drawn inside 
the lesion. It was important to not include any boundary of the lesion or other inhomo-
geneous area inside ROI circle. Second ROI was drawn to background of the image, i.e. 
outside patient. Its size was fixed to approximately 7.5 cm2. An example of noise level 
measurement is shown in Figure 11. 
 
 
Figure 11. a) The white arrows shows the lesions in DCE-MR image. b) The b=0 
s/mm2 DW image. Lesions can be seen in left breast of the figure as bright spot. c) With 
circular tool ROI is drawn carefully inside the lesions and into the background, outside 
the patient. 
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4.4.2 Lesions size 
The measurements of lesions size were performed by MP. The procedure was same as 
described in part 4.3.1. For this analysis size of only malign lesions were considered. 
Lesions were divided into three size groups: small, medium and large for further analy-
sis. 
4.5 Data Analysis Methods 
The statistical significance of different measurements was tested with statistical tests 
using SPSS Statistics 22 -software (IBM, USA). Here the theories of the used tests are 
explained. 
4.5.1 Normalization 
ADC values of lesions were normalized with ADC value obtained from the reference 
point. Normalized ADC value nADC  were determined with following calculation: 
 
reference
lesion
n ADC
ADC
ADC = ,        (16) 
 
where lesionADC  is the ADC value of actual lesion and referenceADC  the  mean ADC val-
ue from reference ROI. The more consistent results with literature values (Table 1) were 
achieved by using the reference point from high intensity area. 
4.5.2 Signal-to-noise ratio 
Signal-to-noise ratio was determined from b=0 s/mm2 diffusion images according the 
NEMA Standards 1-2008. SNR was obtained by dividing the image signal by the image 
noise: 
 
noise
signalSNR = ,        (17) 
 
where signal is the mean signal measured from the lesion and noise is determined from 
the background of the image (outside of tissue area). The change of noise distribution 
must be modified because the SNR measure assumes the noise is Gaussian distributed. 
In this work the noise was corrected as: 
 
66.0
SD
noise = ,         (18) 
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where SD is the standard deviation measured from the background and the factor of 
0.66 ( ( ) 24 pi−≅ ) accounts for the Rayleigh distribution of the noise. The equation 
(17) was used to determine the SNR of the images. SNR was measured from 19 images 
and the final value was averaged from these. 
 
4.5.3 Statistical methods 
Before making any conclusions of statistical research results, they are usually being 
tested. This is often made through a statistical hypothesis testing. First a null-hypothesis 
H0 is formed, which expresses the desired condition, e.g. “sample values are normally 
distributed”. Also an alternative hypothesis H1 is defined, which can be allowed if null-
hypothesis is rejected, e.g. “sample values are not normally distributed”. Next the statis-
tical test is chosen to prove which hypothesis is correct. In this context also a signifi-
cance level α for significant and nonsignificant statistics is defined. Common values for 
significance level are 5% and 1%. 
Not always the hypothesis is selected correctly after the statistical test. Thus, two 
kinds of errors may occur; rejecting the null-hypothesis Ho when it is true or accepting it 
when it is false. These two errors are called as Type I and Type II errors, respectively. 
One way to avoid errors is to select appropriate significance level α. [49; 50] 
Kolmogorov-Smirnov test 
Kolmogorov-Smirnov test utilises cumulative distributions to compare experimental 
results with reference distributions [49]. In this work it was used to test if data samples 
were normally distributed. The null-hypothesis H0 was set as “The distribution of meas-
ured values is Gaussian” and the alternative hypothesis H1 as “The distribution of 
measured values is not Gaussian”. 
 In Kolmogorov-Smirnov test the sample cumulative frequency sum Fn(x) is de-
termined for the data. This is then compared with cumulative distribution function of the 
reference distribution Fe(x): 
 
)()( xFxFD en −= ,        (19) 
 
where D is the difference. If the difference D does not exceed the appointed significance 
level α, the null-hypothesis is accepted. [50] In this thesis Kolmogorov-Smirnov test was 
used to test the normal distribution of samples. 
t test 
The tests for a difference between two means can be divided into two cases: samples 
large enough that the sample standard deviations are not practically different from 
known and the case of small-sample estimated standard deviations. The mean test uses a 
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standard normal distribution (z distribution) in the first case and a t distribution in the 
second one, and the tests are called z test and t test, respectively. [50] 
 Before the actual t test, the normality of the sample is tested (e.g. with Kolmogo-
rov-Smirnov test). Then the null- and alternative hypotheses are specified. The null hy-
pothesis H0 is usually set as” the means are the same”, H0: 21 µµ = . The alternative hy-
pothesis H1 “the means are not the same” may be set as two-sided test, H1: 21 µµ ≠  or as 
one-sided test, H1: 21 µµ <  or H1: 21 µµ > . By choosing the significance level, the critical 
t value can be determined from statistics tables. For the sample, the t value is calculated 
as: 
s
t 21
µµ −
= ,         (20) 
 
where s is determined through following equation: 
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where in is sample size and is is sample’s standard deviation. Finally the null hypothesis 
is either accepted or rejected, depending on where the statistics lies relative to the criti-
cal value. [50] In this work t test was used to test if mean ADC values of benign and 
malign lesions were statistically significantly different. 
The intra-class correlation 
The intra-class correlation is a method for estimating the reliability of repeated meas-
urements. The procedure is based upon the analysis of variance and the estimation of 
variance components. [51] It was introduced by Ronald Fisher [52]. The ICC values 
vary from 0 to 1 and the closer to unite they are, the more reliable the tested method is. 
The repeated measurements were analysed with SPSS using the averages of intra-class 
correlation coefficients (ICCs) with absolute agreements. 
Sensitivity and Specificity 
Sensitivity tells the proportion of true positive cases, so the event of a predicted disease 
being present. Specificity instead, also called true negative, is the event of predicting no 
disease when disease is absent. [50] In this thesis these concepts were used alongside 
with the ADC threshold values; for example threshold ADC value for malign lesions X. 
Sensitivity is determined with ratio: 
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Respectively the specificity is described with ratio: 
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:  ;<=>?@	AB	>?FEOF	C?DEAFD	GEH	IJK	LMC<?	O@?M?@	HMF	N;<=>?@	AB	>?FEOF	C?DEAFD   (23) 
 
Sensitivity and specificity were used to evaluation the cutoff ADC value of malign le-
sions.  
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5. RESULTS 
In this thesis four different studies were performed: Comparison of mean ADC values 
of benign and malign lesions, repeatability of ADC measurements, correlation between 
SNR and ADC values, and effect of lesion size to ADC values. The results of these 
studies are introduced next. 
5.1 Comparison of mean ADC values 
ADC values of lesions were measured as described in Chapter 4.3.1. Malign suspect 
were excluded from statistical analysis due to small sample size. ADC values of lesions 
were normalized by dividing the ADC value of lesions with ADC values of reference 
tissue. The distribution of original ADC values of 48 malign and 8 benign lesions is 
shown in Figure 12 and normalized ADC values in Figure 13. Also box plot is included.  
 
 
Figure 12. Measured ADC values of malign and benign lesions. Box plot shows the 
median of the sample (middle line inside the box) and 25 to 75 percentiles of data. The 
whiskers represent the minimum and maximum of the sample, i.e. range of values. 
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Figure 13. Normalized ADC values of malign and benign lesions. Box plot shows the 
median of the sample (middle line inside the box) and 25 to 75 percentiles of data. The 
whiskers represent the minimum and maximum of the sample, i.e. range of values. 
 
It can be seen in Figure 12 and 13 that ADC values of malign and benign lesion overlap. 
The normalization makes the box plot of malign sample narrower. The benign sample 
distribution does not change much in normalization. The statistical information of the 
data is also gathered in to Table 5. 
 
Table 5. Statistical information of the ADC measurement. 
Type of  
lesion 
Number of  
lesions 
ADC values Normalized ADC values 
Range  
(x10-3 mm2/s) 
Mean 
(x10-3 mm2/s) 
Range  
(x10-3 mm2/s) 
Mean  
(x10-3 mm2/s) 
Benign 8 0.68 – 1.38 1.0329 0.54 - 1.23 0.800.23 
Malign 48 0.130 – 1.43 0.7623 0.18 - 1.05 0.630.20 
 
Normal distribution of the ADC values was tested with Kolmogorov-Smirnov separate-
ly for benign and malign samples. Both normalized and not normalized data were con-
sidered as normally distributed, with significance level 0.05 test (Table 6). The statisti-
cal significance of difference between malign and benign means was tested with Inde-
pendent-Samples’ t test. The malign and benign lesions ADC value means were signifi-
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cantly different for both normalized (0.03) and not normalized cases (0.01) with signifi-
cance level of 0.05. These results are presented in Table 6. 
 
Table 6. Results for testing significance of benign and malign mean difference. 
Statistical test 
Significance 
Not normalized Normalized 
Kolmogorov-Smirnov  
test 
Benign 0.08 0.20 
Malign 0.20 0.20 
Independent-Samples  
T test 
 0.01 0.03 
5.2 Repeatability of ADC measurement  
ADC measurements were repeated for 16 randomly chosen malign lesions. The meas-
urement results for real ADC values are shown in Figure 14 and for normalized ADC 
values in Figure 15. Old measurement results from corresponding 16 lesions are plotted 
beside for comparison. 
 
 
Figure 14. ADC values from repeated measurement on left and for comparison the cor-
responding ADC values from original measurement on right. Box plot shows the medi-
an of the sample (middle line inside the box) and 25 to 75 percentiles of data. The 
whiskers represent the minimum and maximum of the sample, i.e. range of values. 
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Figure 15. Normalized ADC values from repeated measurement on left and for compar-
ison the corresponding ADC values from original measurement on right. Box plot 
shows the median of the sample (middle line inside the box) and 25 to 75 percentiles of 
data. The whiskers represent the minimum and maximum of the sample, i.e. range of 
values. 
 
From Figures 14 and 15 can be seen that the medians lie at same levels both in original 
and repeated measurements and distributions and ranges of samples are similar. Nor-
malization makes the box plot wider i.e. ADC values spread around median a little. The 
statistical information of these measurements is collected into Table 7. 
 
Table 7. Statistical information of the repeatability measurement 
Measurement 
ADC values Normalized ADC values 
Range  
(x 10-3 mm2/s) 
Mean 
(x10-3 mm2/s) 
Range  
(x10-3 mm2/s) 
Mean  
(x10-3 mm2/s) 
Original 0.23 – 1.43 0.77 0.18 - 1.04 0.63 
Repeated 0.30 – 1.36 0.76 0.26 - 1.00 0.60 
 
The normal distribution of old and new ADC values of lesions was tested with 
Kolmogorov-Smirnov test. Both old and repeated samples (normalized and not normal-
ized) were considered normally distributed (Table 8) with significance level 0.05. The 
reliability of the repeated measurements was tested with ICC values and the reliability 
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test was performed with absolute agreement. ICC value for not normalized data was 
found 0.99 and for normalized 0.94 (Table 8). Thus repeatability was excellent. 
 
Table 8. Results for statistical reliability test. 
Statistical test 
Significance 
Not normalized Normalized 
Kolmogorov-
Smirnov test 
Old meas. 0.06 0.20 
Repeated meas. 0.03 0.20 
Reliability test  0.99 0.94 
5.3 Correlation between SNR and ADC values 
The mean SNR value was determined with equation (17) from 19 b=0 s/mm2  DW im-
ages. The obtained SNR value was 40.6 ± 15.6 
SNR values were compared with ADC values of 19 random lesions (the original 
ADC values, not repeated measurements). The true ADC values were used, i.e. not 
normalized values. Comparison was performed with correlation calculation in SPSS 
software. First the normality of ADC value distribution was tested with Kolmogorov-
Smirnov test and both variables were considered as normally distributed with signifi-
cance level 0.05 (Table 9). 
 
Table 9. Normal distribution test for ADC and SNR values 
Kolmogorov-Smirnov Test ADC SNR 
Significance 0.08 0.20 
 
Next the actual correlation was tested with a correlation matrix, shown in Table 10. The 
correlation coefficient between ADC and SNR was positive (correlation coefficient 
0.49) and statistically significant (significance level 0.05). The not normalized and nor-
malized ADC values are also plotted against SNR values in Figures 16 and 17, respec-
tively.  
 
 Table 10. Correlation matrix for ADC and SNR values 
Correlation matrix, N=19 ADC SNR 
ADC Pearson Correlation 
 Significance 
 
1 
- 
0.49 
0.03 
SNR Pearson Correlation 
 Significance 
 
0.49 
0.03 
1 
- 
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Figure 16. Graphical presentation of correlation between SNR and not normalized ADC 
values. Line shows least square fit for correlation. 
 
 
 
Figure 17. Graphical presentation of correlation between SNR and normalized ADC 
values. Line shows least square fit for correlation. 
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From Figure 16 and 17 can be seen that there is a slight trend that ADC values increase 
while SNR values increase. However, like the correlation coefficient (0.49) shows, the 
correlation is not very strong, because it is far away from unity. 
5.4 Effect of lesion size to ADC values 
Effect of lesion size to ADC values was tested with the repeated measurements. The 
ICC values were calculated for different lesion size groups: small, medium, and large. It 
was seen that ICC increased with increasing lesion size (Table 11.) 
 
Table 11. ICC results for three different size groups of lesions. 
Size group Size range (mm2) N 
ICC 
Not normalized Normalized 
small 0.21-0.24 5 0.96 0.81 
medium 0.31-0.51 6 0.99 0.92 
large 0.67-1.45 5 0.995 0.98 
 
Similarly with previous chapter, the correlation between lesion size and ADC values 
was analysed with correlation matrix. The normal distribution of data was already tested 
in part 5.1. The correlation was tested for both not normalized and normalized ADC 
values, shown in correlation matrix (Table 12).  
 
Table 12. Correlation matrix for area, normalized and not normalized ADC values. 
Correlation matrix, N=48 Area ADC, not  
normalized 
ADC,  
normalized 
Area 
Pearson Correlation 1 0.22 0.15 
Significance - 0.14 0.30 
ADC, not  
normalized 
Pearson Correlation 0.22 1 0.80 
Significance 0.14 - 0.00 
ADC, 
 normalized 
Pearson Correlation 0.15 0.80 1 
Significance 0.30 0.00 - 
 
Lesion size and ADC values show poor correlation for both normalized (0.15) and not 
normalized ADC values (0.22). Moreover, results are not statistically significant 
(>0.05). Consequently, according to this study, no correlation can be seen between le-
sions size and ADC values. In Figures 18 and 19 the not normalized and normalized 
ADC values are plotted against lesion size. 
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Figure 18. Graphical presentation of correlation between lesion size and not normalized 
ADC values. Line shows least square fit for correlation. 
 
 
Figure 19. Graphical presentation of correlation between lesion size and normalized 
ADC values. Line shows least square fit for correlation. 
 
Figures 18 and 19 support the result of correlation matrix. There is not any correlation 
between ADC and lesion size. 
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6. DISCUSSION 
Diffusion-weighted imaging offers the potential novel contrast mechanism in MR imag-
ing. Significant advantage of DWI over traditional contrast-enhanced MRI is its high 
sensitivity to change in microscopic water diffusion without the need for intravenous 
contrast material injection. Application of DWI in breast cancer diagnostics has been 
reported widely [34; 40; 42; 43; 53]. These studies show that mean ADC values of ma-
lignant tumours are significantly lower compared to benign lesions. Thus DWI is prom-
ising tool for breast cancer characterization. [7; 18] In this chapter the results introduced 
in previous chapter are discussed. Moreover, the criticisms towards the measurement 
and towards the method in general are presented. Finally, the clinical challenges and 
future prospects are discussed. 
6.1 Results 
Four different studies were performed: Comparison of mean ADC values of benign and 
malign lesions, repeatability of ADC measurements, correlation between SNR and ADC 
values, and effect of lesion size to ADC values. The results are collected here and dis-
cussed. 
Comparison of mean ADC values 
The mean normalized ADC values were measured to be 0.80 ±0.23 x10-3 mm2/s for be-
nign lesions and 0.63±0.20x10-3 mm2/s for malign lesions and there means were found 
to be statistically significantly different. These ADC values are considerably lower than 
values found in literature (Table 1). The results in Table 1 are mainly obtained with two 
different b-values and in this study the images were produced with four b-values (b=0, 
50, 500, and 1500 s/mm2). But according to study of Bogner et al. [35] this should not 
affect the ADC values this dramatically. Studies listed in Table 1 do not explain in de-
tail the reasons for choice of reference point in tissues. This might be one differing fac-
tor affecting the dissimilarity in result. 
Marini et al. [40] defined various threshold values for benign and malign lesion 
in their study. They for example defined thresholds as meanbenign -1 SD and  
meanbenign + 2 SD. With modification to their method, the cutoff value for malign le-
sions was determined in this study to be meanbenign + 1 SD = 0.83 x10-3 mm2/s. With this 
cutoff value the sensitivity of the method here was 83.3% and specificity of 37.3%. The 
low value of specificity is not very promising, but like was previously said, the benign 
sample was really small. 
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Repeatability of ADC measurements 
In repeatability measurements the mean ADC value for malign lesion was obtained to 
be 0.60 x 10-3 mm2/s. The repeatability was found excellent: the intra-class correlation 
was found 99.3 for not normalized ADC values and 94.4 for normalized values. This is 
in good line with study of O’Flynn et al. [54] who found ICC value of 0.93 for repro-
ducibility of breast lesion ADC measurements.  
The lower ICC value with normalized values was predictable. The lesion posi-
tion is relatively easy to find with the help of DCE-MRI images, but the location of ref-
erence point depends how the measurer happens to determine it. Often reference ROI 
was also measured from different slice than the actual lesion ROI, which increases the 
inaccuracy in repetition. 
Correlation between SNR and ADC values 
The mean SNR value of b=0 s/mm2 images was determined to be 40.6 ± 15.6. Mukher-
jee et al. [55] suggest that SNR of the b=0 s/mm2 images of DTI acquisition should be 
at least 20 in order to determine reliable measures of parameters such as FA (equation 
15) in brain structures. This can be used as suggestive value also for breast tissue which 
implies that the obtained result for SNR is good. In the correlation study between SNR 
and ADC values only poor correlation was discovered with correlation coefficient of 
0.49 while best correlation is described with unity. Scatter plots (Figures 16 and 17) 
support this obtained correlation coefficient value: there is only slight positive trend 
between SNR and ADC values. 
Effect of lesion size to ADC values 
Effect of lesion size to ADC values was studied in two ways: ICC values in three differ-
ent size groups (Table 11) and with correlation matrix (Table 12). The ICC values in-
creased with lesion size in all three size groups. This makes sense because larger lesions 
are easier to distinguish in ADC maps and so also ROIs are easier to draw into same 
locations. ICC values with normalized ADC was smaller than with not normalized ADC 
values. Again this can be explained with the difficulty with reference point repeatability. 
The correlation matrix (Table 12) and scatter plots (Figure 18 and 19) showed that ADC 
values were not dependent on lesions size. This means that for example large lesions 
does not have stronger intensity in ADC maps than small lesions. 
6.2 Reliability of the measurements 
The studies performed had several limitations. First, the number of benign lesion (only 
eight) was very small to make reliable statistical analysis. In other studies [36-38; 40-
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43] sample sizes have been over 20 for benign and malign lesions, like can be seen in 
Table 1. Moreover, in this study the benign lesions were not classified so the benign 
samples could have included any type of benign lesions. Therefore the obtained mean 
ADC of benign lesions would also depend on the different histological types included in 
the analysis. 
  Second, the ROI placement in ADC map affected significantly on measured 
ADC values. Even a small shift on ADC map could change ADC value dramatically 
and lead to false measurement result.  Especially in the case of small lesions the accu-
rate location of ROI on ADC map was difficult and possible only with the help of DCE-
MR image comparison. The results of repeatability measurements also support this; 
bigger lesions were had better repeatability. In many studies [40; 53; 56] lesions smaller 
than 1 cm in diameter are considered difficult to detect in ADC maps. 
6.3 Challenges in clinical applicability of breast DWI 
DWI in a promising tool for breast imaging, but there are many challenges and limita-
tion that need to be considered before wider clinical usability. In this chapter the chal-
lenges related to imaging parameters and ADC measurement protocol are discussed. 
Imaging challenges 
One challenge related to DWI as an imaging technique is its limited Signal-to-noise 
ratio. Relatively good SNR is important for tissue contrast and accurate ADC measure-
ment. A higher SNR can also be used to increase the spatial resolution of DW imaging, 
when the detection of small lesions is easier [31]. Methods to improve SNR include for 
example increasing of voxel size and increasing the number of averages. One important 
factor is the choice of b values. Higher b-values decrease the SNR [57] but on the other 
hand a higher b-value improves contrast resolution [7; 31]. 
One of the greatest technical challenges in DWI is the effect of macroscopic mo-
tion, while retaining the sensitivity to the microscopic motion [58]. Movement of patient 
causes image misregistration, which leads to false ADC values. Only way to avoid pa-
tient movement is to make sure that patient is lying in a comfortable position and to 
optimize imaging protocol so that imaging time is minimized. [18] 
  Like discussed in chapter 3.3.4 - Imaging protocol optimization DW imaging of 
breast is technically challenging due to its location: tissue-air interfaces at skin surface 
and at thorax give rise to susceptibility artefacts and high fat tissue content causes image 
artefacts. This is why good fat suppression technique and shimming are needed. Opti-
mal fat suppression is important for good contrast between normal breast tissue and 
lesions in ADC map. [18] However, fat suppressions decreases signal in DW images 
and even the most optimal suppression techniques are imperfect. Fat signal that is not 
fully suppressed may appear to increase the relative signal strength at high b-value DWI 
because the nonfat tissues are losing signal as diffusion weighting increases, whereas 
the remaining fat signal is not affected by diffusion weighting. [7] Moreover, the ADC 
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values of lesions including fat content is varied depending the used fat suppression 
technique and may lead to misdiagnosis [59]. 
Challenges in ADC measurement 
Hand-drawn ROI-based techniques have limitations and set challenges to DWI. Like 
found in this thesis and in several studies [53; 56], ROI placement in ADC map is really 
critical and gives rise to measurement errors. The obtained ADC values from hand-
drawn ROIs depends greatly on the measurer so the reproducibility and comparison of 
different studies is complicated. Moreover, hand-drawn ROI-based techniques are time 
consuming. [7] Development of semiautomatic methods is needed for more reliable and 
comparable results. Some studies of this development are made [60] and the results 
seem promising. However, if DCE-MRI figures are used to help in lesion location, er-
rors might arise in shifts in patient position between imaging sequences. [7] 
The ADC value of breast tissue may be somewhat dependent of menstrual cycle 
phase. This variation arises from the change in water content in the breast tissue during 
the menstrual cycle. Partridge et al [61] found the variation of breast ADC to be 5.5% 
across different menstrual phases. Trend showed that decreased ADC values in the sec-
ond week of cycle and a peak in ADC during the week prior to menstruation. However, 
other studies [54; 62] have not detect significant difference in ADC values during men-
strual cycle. 
6.4 Future prospects 
Studies carried out in this thesis give promising results about breast DWI and thus it 
would be interesting to continue the studies. In the future it would be interesting to ex-
amine the optimization of ADC maps with different b-values. Also studies with several 
different malign lesion types would be natural next step. 
 In general DWI seems a promising tool for breast cancer imaging and character-
ization. The most significant advantage of DW imaging over traditional contrast-
enhanced MR imaging is its high sensitivity in the detection of breast cancer. DW imag-
ing has strong potential as an adjunct MR imaging technique to reduce false positive 
results and unnecessary biopsies. This tumor characterization method is the most stud-
ied application of DW imaging.  [7; 18] 
In addition to this, screening MR imaging of breast without added contrast mate-
rial is a prospective application for DW imaging. Conventional screening with DCE-
MRI is highly sensitive for identification of lesions but it is not suitable for all patients; 
used gadolinium-based contrast material is associated with nephrogenic systemic fibro-
sis [63]. Moreover, DCE-MRI is more time consuming and expensive than DWI of the 
breast. Nevertheless, the potential of DWI as a noncontrast alternative for DCE-MRI 
screening method been only little studied so it needs further examination. [7; 18] 
DWI has also potential in predicting the effect of neoadjuvant chemotherapy 
[64; 65]. Tumor response is typically measured by change in size but alternative mark-
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ers such as tumor cellularity, vascularity, or rate of cell proliferation are possible meas-
urable variables with DWI. ADC value may provide an earlier biomarker for tumor re-
sponse. Early prediction of the effect of chemotherapy would allow timely optimization 
of the therapy protocol to ensure the best therapeutic effect. [7; 18] 
Before wide clinical use the standard protocol for DW breast imaging has to be 
agreed; results obtained around the world needs to be comparable. For example choice 
of b-values and number of them affect significantly on the obtained ADC values [31; 
35]. Moreover, if DWI is used along with DCE-MRI the effect of contrast agent to the 
ADC values needs to be taken into account; studies [66; 67] show that ADC values are 
lower if DWI is performed after contrast enhancement. Firat et al [67] suggest that at 
least 6-10 min delay is preferable before DW imaging, which is not favoured in clinical 
use: it increases the imaging time and may lead to position shifts between imaging se-
quences. This is why DW imaging is usually performed before the contrast-enhanced 
imaging. And like discussed in chapter 6.3 –Imaging challenges the used fat suppres-
sion technique also affect into the measured ADC values so it needs to be standardized 
as well. And of course the ADC value normalization method needs universal guidelines 
so that measurement results are comparable. 
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7. CONCLUSION 
In this Master of Science thesis the ADC values of malign and benign breast lesions 
were examined through four studies: Comparison of mean ADC values of benign and 
malign lesions, repeatability of ADC measurements, correlation between SNR and ADC 
values, and effect of lesion size to ADC values. In the measurements the breast tissue 
changes of 45 patients (age range 45-83 years) were used. These changes included 48 
ductal carcinomas in situ and 8 benign changes. 
The normalized mean ADC values for benign lesions was found  
0.80 ± 0.23 x10-3 mm2/s and for malign lesions 0.63 ± 0.20 x10-3 mm2/s and they were 
found significantly different. The cutoff value for malign lesions was determined  
0.83 x10-3 mm2/s with sensitivity of 83.3% and specificity of 37.3%. The measurement 
method showed excellent repeatability, especially with big lesions. ADC and SNR val-
ues were not found to be correlated with each other.  
The results of this thesis were promising and in line with the literature values. 
The obtained cutoff value has the best direct clinical applicability: radiologists can use it 
as a guidance tool in breast cancer evaluation. It tells that when ADC value of lesion is 
less than 0.83 the lesions can be strongly considered as malign and when ADC value is 
greater than 0.83, it is strongly benign. This is valuable information for example when 
doctor is considering the need for further imaging or histological biopsies. 
Overall DWI is a potential imaging method for oncological applications. It ena-
bles the lesions characterization with its microscopic diffusion sensitive imaging se-
quence. In breast cancer imaging DWI has multiple advantages over conventional con-
trast-enhanced MRI, for example it is cheaper and faster than DCE-MRI and to top it all 
it increases the sensitivity of breast lesion characterization. 
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